Roche brings new formulation of saquinavir to FDA. Food and Drug Administration.
Cadman
J
J
D004304:Dosage Forms; D017277:Drug Approval; D017320:HIV Protease Inhibitors / Q000008:administration & dosage*; D019258:Saquinavir / Q000008:administration & dosage*; D014481:United States; D014486:United States Food and Drug Administration
D004304:Dosage Forms; D017320:HIV Protease Inhibitors; D019258:Saquinavir